KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Zimmer Biomet Holdings (ZBH) Cost of Revenue (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of Cost of Revenue data on record, last reported at $559.3 million in Q3 2025.

  • For Q3 2025, Cost of Revenue rose 3.84% year-over-year to $559.3 million; the TTM value through Sep 2025 reached $2.2 billion, up 4.42%, while the annual FY2025 figure was $2.5 billion, 13.81% up from the prior year.
  • Cost of Revenue reached $559.3 million in Q3 2025 per ZBH's latest filing, down from $586.7 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $586.7 million in Q4 2024 and bottomed at $280.9 million in Q4 2021.
  • Average Cost of Revenue over 5 years is $508.5 million, with a median of $518.6 million recorded in 2023.
  • Peak YoY movement for Cost of Revenue: dropped 18.18% in 2021, then skyrocketed 85.23% in 2022.
  • A 5-year view of Cost of Revenue shows it stood at $280.9 million in 2021, then surged by 85.23% to $520.3 million in 2022, then grew by 3.57% to $538.9 million in 2023, then grew by 8.87% to $586.7 million in 2024, then dropped by 4.67% to $559.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cost of Revenue were $559.3 million in Q3 2025, $586.7 million in Q4 2024, and $538.6 million in Q3 2024.